Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GBIO | Common Stock | Options Exercise | +3.35K | +35.39% | 12.8K | Jul 15, 2024 | Direct | F1 | ||
transaction | GBIO | Common Stock | Tax liability | -$2.88K | -983 | -7.68% | $2.93 | 11.8K | Jul 15, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GBIO | Restricted Stock Units | Options Exercise | $0 | -3.35K | -8.33% | $0.00 | 36.8K | Jul 15, 2024 | Common Stock | 3.35K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Each restricted stock unit represents the right to receive one share of the company's common stock. |
F2 | The grant of 53,550 restricted stock units was made on April 5, 2023. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on April 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter. |